Page 124 - Read Online
P. 124

Sioka et al. Neuroimmunol Neuroinflammation 2018;5:18  I  http://dx.doi.org/10.20517/2347-8659.2018.06                  Page 3 of 3

               2.   Olsson A, Oturai AB, Sondergaard HB, Sellebjerg F, Oturai PS. Bone microarchitecture and bone mineral density in multiple sclerosis.
                   Acta Neurol Scand 2018;137:363-9.
               3.   Huang Z, Qi Y, Du S, Chen G, Yan W. BMI levels with MS Bone mineral density levels in adults with multiple sclerosis: a meta-
                   analysis. Int J Neurosci 2015;125:904-12.
               4.   Kepczynska K, Zajda M, Lewandowski Z, Przedlacki J, Zakrzewska-Pniewska B. Bone metabolism and vitamin D status in patients
                   with multiple sclerosis. Neurol Neurochir Pol 2016;50:251-7.
               5.   Zengin Karahan S, Boz C, Kilic S, Can Usta N, Ozmenoglu M, Altunayoglu Cakmak V, Gazioglu S. Lack of association between pulse
                   steroid therapy and bone mineral density in patients with multiple sclerosis. Mult Scler Int 2016;2016:5794910.
               6.   Ayatollahi A, Mohajeri-Tehrani MR, Nafissi S. Factors affecting bone mineral density in multiple sclerosis patients. Iran J Neurol
                   2013;12:19-22.
               7.   Coskun Benlidayi I, Basaran S, Evlice A, Erdem M, Demirkiran M. Prevalence and risk factors of low bone mineral density in patients
                   with multiple sclerosis. Acta Clin Belg 2015;70:188-92.
               8.   Sioka C, Kyritsis AP, Fotopoulos A. Multiple sclerosis, osteoporosis, and vitamin D. J Neurol Sci 2009;287:1-6.
               9.   Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, Georgiou I, Pelidou SH, Kyritsis AP, Fotopoulos A. Vitamin D
                   receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed 2011;10:3.
               10.  Weinstock-Guttman B, Gallagher E, Baier M, Green L, Feichter J, Patrick K, Miller C, Wrest K, Ramanathan M. Risk of bone loss in
                   men with multiple sclerosis. Mult Scler 2004;10:170-5.
               11.  Zikan V, Tyblova M, Raska I, Havrdova E, Luchavova M, Michalska D, Kubena AA. Bone mineral density and body composition in
                   men with multiple sclerosis chronically treated with low-dose glucocorticoids. Physiol Res 2012;61:405-17.
               12.  Sioka C, Fotopoulos A, Papakonstantinou S, Georgiou A, Pelidou SH, Kyritsis AP, Kalef-Ezra JA. The effect of menarche age, parity
                   and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients. Mult Scler Relat Disord 2015;4:287-90.
               13.  Terzi T, Terzi M, Tander B, Canturk F, Onar M. Changes in bone mineral density and bone metabolism markers in premenopausal
                   women with multiple sclerosis and the relationship to clinical variables. J Clin Neurosci 2010;17:1260-4.
   119   120   121   122   123   124   125   126   127   128   129